Executive Director’s Report
On behalf of the management of Zambart, I am pleased to introduce Zambart’s Annual report for 2017–18.
The two years covered by this report provided several challenges and opportunities for growth and development for the Organization. Having evolved from a research collaboration established between the University of Zambia, School of Medicine and the London School of Hygiene and Tropical Medicine as far back as 1988, Zambart has grown into a fully-fledged Research Organization that is internationally recognized for the high-quality research conducted, with public health impact. From its beginnings as
primarily a TB/HIV research organization, that resulted in the coining of its names as the Zambian AIDS-Related Tuberculosis Project (hence the acronym ZAMBART), research activities have expanded over the ensuing years to other areas of public health concern, while retaining a focus on HIV and TB. In view of this development, Zambart changed its name from an acronym, to a name. However, for many of our collaborators, and indeed even for some Zambart staff, the change from an acronym to a name has very slowly taken root.